Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
SGP.OQ - SpyGlass Pharma Inc
SpyGlass Pharma Inc at Goldman Sachs Healthcare Conference
Jun 10, 2026 / 02:40PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Okay. Good morning, everybody. I'm not sure I need this microphone, but hopefully you can hear me okay. I'm Patrick Mooney, CEO of Spyglass Pharma. With me today, Jean Verret, our CFO, and James Denoel, our Chief Operating Officer. It's a privilege to share the story with you. Spyglass has been a private company for seven years, and we just took the company public in February of this year. Which is funding our Phase 3 execution of our enrollment as well as advancing prep for commercialization in time. But thrilled to share the story. These are our standard disclaimers. We will be sharing some forward-looking statements today.
Spyglass is essentially addressing two of the world's leading causes of preventable
Trustpilot
